SEC Form 4 · accession 0000899243-19-005883
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ralf Kuriyel
Officer — Senior VP, R&D
Period of report
Feb 28, 2019
Accepted (ET)
Mar 4, 2019 · 6:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000730272
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 28, 2019 | A | 4,234 | $0.00 | A | 16,528 | D | |
| Common Stock | Feb 28, 2019 | S | 185 | $59.16 | D | 16,343 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $59.52 | Feb 28, 2019 | A | 4,042 | A | — | Feb 28, 2029 | Common Stock | 4,042 | 4,042 | D |
Explanation of responses
- F1Mr. Kuriyel was awarded 4,234 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- F2Sale of 185 shares in the open market to cover tax liability resulting from the release of restricted stock units.
- F3One third of the stock options will vest and become exercisable annually on February 28, 2020, February 28, 2021 and February 28, 2022.